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The diagnostics of fresh cartilage injuries in the early-state is important for the
prevention of post-traumatic osteoarthritis (PTOA). Currently, the sensitivity of
diagnostic techniques, including magnetic resonance imaging (MRI), clinical exami-
nation, native X-ray imaging, and arthroscopic examination, have not been sufficient
for detecting fresh cartilage injuries or the incipient degeneration of the tissue sur-
rounding the injury.
Contrast enhanced computed tomography (CECT) enables the detection of fresh
cartilage injuries. However, it requires two images first one immediately after the
contrast agent administration into synovial fluid and second one 45 minutes after the
administration. The first image allows the accurate segmentation of the cartilage
surface since contrast agent diffusion diminishes the contrast at the cartilage-synovial
fluid interface soon after contrast agent administration. Delayed imaging, at 45
minutes after the administration, enables the detection of cartilage injuries and
degenerations as elevated contrast agent concentration at injured or degenerated
tissue.
Performing two scheduled imaging is logistically challenging and it doubles the
patient exposure to the radiation. Therefore, in this thesis we develop a dual contrast
method that will allow the diagnostics of fresh cartilage injuries and degeneration
of the surrounding tissue conducting only one image 45 minutes after dual contrast
agent administration. As a result, this method will enhance the CECT diagnostics
of fresh cartilage injuries among with other joint diseases, thus leading to better
repair and prevention of PTOA. Furthermore, the radiation dose will be significantly
reduced as compared to the current method used in CECT diagnostics of a knee joint
and the imaging will be relieved logistically.
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11. INTRODUCTION
Articular cartilage covers the ends of articulating bones, such as femur and tibia.
Its damage is a relatively common injury and can cause joint pain, swelling, and im-
mobility. The damage can also initiate post-traumatic osteoarthritis (PTOA) [1,2].
PTOA is a joint disease in which articular cartilage degenerates gradually. Recent
findings suggest that pharmaceutical interventions, in addition to surgical interven-
tions, can be used to prevent the development of PTOA but only if the injury is
detected early [3–5]. Thus, for effective surgical or pharmaceutical treatment and
prevention of PTOA, early diagnostics of cartilage injury is important. With cur-
rent diagnostic techniques, including magnetic resonance imaging (MRI), clinical
examination, native X-ray imaging, and arthroscopic examination, the detection of
fresh cartilage injuries and changes in surrounding tissues is difficult or even im-
possible. Moreover, the current techniques can only detect late-state and advanced
tissue changes. For this reason, new enhanced diagnostic methods for detection and
grading of cartilage injuries would improve the early selection of treatment, thus
reducing the risk for PTOA.
In contrast enhanced computed tomography (CECT) imaging, contrast agents
are introduced to enhance the interface of the synovial fluid and cartilage, as the
natural contrast in X-ray at this interface is almost non-existent. Superficial collagen
disruption, proteoglycan (PG) loss, and increased water content are the first signs of
cartilage injury [6,7]. They increase the permeability of the tissue, thereby affecting
diffusion of contrast agents into articular cartilage [8, 9]. By observing changes in
contrast agent diffusion into cartilage, acute injuries can be detected using CECT
[10, 11]. CECT imaging of a knee joint can be conducted using cone beam CT
(CBCT) scanner. It utilizes a conical X-ray beam to acquire images covering a large
volume with a single rotation around the knee. The main advantages of CBCT are
low radiation doses and a high resolution [12].
In a recent study, CECT was applied in vivo for the first time [10]. The study con-
cluded that the maximum contrast agent concentration in the cartilage was achieved
at 30–60 min after the injection into the joint. Currently, CECT of a knee joint is
conducted immediately after and at 45 minutes after contrast agent injection into the
synovial fluid. The first image is needed for accurate segmentation of the cartilage
surface since contrast agent diffusion diminishes the contrast at the cartilage-synovial
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fluid interface. Delayed imaging, at 45 minutes after the administration, is required
for the detection of cartilage injuries due to elevated contrast agent concentration
at injured or degenerated tissue.
The X-ray computed tomography (CT) diagnostics of articular cartilage injuries
can be improved significantly by introducing a novel dual contrast method. In
this thesis, a dual contrast agent containing a mixture of an iodine-based contrast
agent (ioxaglate) and suspension of nano-sized bismuth oxide particles is developed
and employed for evaluation of cartilage injuries. We hypothesize that since these
nanoparticles are relatively large (90-210 nm in diameter), they are unable to diffuse
into cartilage; therefore, the contrast at the interface between synovial fluid and car-
tilage can be retained at high level due to the nanoparticles, even at the 45 minutes
after the contrast agent administration. Ioxaglate, on the other hand, is required
since its diffusion into cartilage allows the quantitative evaluation of the tissue com-
position. Bismuth oxide nanoparticles (BiNPs) are selected for this study due to
their high X-ray attenuation coefficient, inexpensive price, and low toxicity [13].
The aim of this study is to verify the potential of the dual contrast method
by imaging intact and injured osteochondral plugs using a X-ray microtomography
(microCT). We hypothesize that the dual contrast method will provide diagnostic
information non-reachable with any current diagnostic modality. In clinical use, this
technique may lead to better diagnostics of various joint conditions, especially with
fresh cartilage injuries, thus leading to better repair and prevention of PTOA. As a
result, the radiation dose will be significantly reduced as compared to the current
method used in CECT diagnostics of a knee joint. In addition, the application
of the dual contrast method will potentially improve image quality allowing the
fully automatic segmentation of the CBCT knee joint images. This would enhance
the diagnostics of various joint conditions, but also enable more straightforward
modelling of the joint function and the planning of interventions.
32. ARTICULAR CARTILAGE
Articular cartilage is a highly specialized connective tissue covering the ends of ar-
ticulating bones, such as femur and tibia [14, 15]. It provides a smooth, lubricated
surface for articulation of the bones, together with the lubricating synovial fluid and
facilitates the transmission of load with low friction coefficient [14, 16]. Articular
cartilage also sustains great dynamics and static forces between articulating bones.
In this regard, articular cartilage injuries jeopardize the correct mechanical function
of the joint, exposing the articulating surfaces to mechanical overload. This over-
loading can potentially initiate further tissue damage. Thus, the preservation and
health of articular cartilage is important for joint health also due to limited capacity
for intrinsic healing and repair of articular cartilage.
2.1 Structure and Function
Articular cartilage is in human a 2 to 3 mm thick porous viscoelastic fiber reinforced
tissue [17]. Cartilage tissue is referred as biphasic material, composed of a solid phase
and a fluid phase [18]. The main components of the solid phase are collagen (15-
22% of wet weight (w. w.) [14]) and PGs (4-7% of w. w. [14]). The fluid phase
consists of interstitial water (60-80% of w. w. [19]) and electrolytes. Together the
two phases form the extracellular matrix (ECM) which surrounds the cartilage cells,
chondrocytes.
Articular cartilage can also be divided into three zones based on the composition
and structure of the cartilage in different depths [20]. The zones are the superficial
zone, the middle zone, and the deep zone (Fig. 2.1) [16]. The superficial zone is
responsible for most of the tensile properties of cartilage, enabling it to resist the
sheer, tensile, and compressive forces imposed by articulation. The middle zone
provides an anatomic and functional bridge between the superficial and deep zones,
and it is the first line of resistance to compressive forces. Finally, the deep zone
gives cartilage its greatest resistance for compressive forces since the collagen fibers
in the deep zone are arranged perpendicular to the articular surface.
Cartilage under the deep zone is called calcified cartilage. It plays an important
role in securing the cartilage to bone by attaching the collagen fibers of the deep
zone to subchondral bone as shown in Fig. 2.1. Moreover, the cell population is
scarce and chondrocytes are hypertrophic in calcified cartilage.
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Figure 2.1: A schematic illustration of articular cartilage. The collagens are oriented paral-
lel to the articular surface in the superficial zone, while in the middle zone the orientation
is more random. In the deep zone, the orientation is perpendicular to the cartilage-
subchondral bone interface. The tidemark represents the calcified-noncalcified cartilage
interface.
Collagen fibers (primarily, type II collagen) form the internal skeleton of articular
cartilage. They are tightly packed, aligned to the articular surface, and extensively
cross-linked. This unique structure gives cartilage its high tensile strength and
shear stiffness [21, 22]. The preferential direction of the collagen varies between
the cartilage zones. In the superficial zone, the fibers are oriented in parallel to
the surface and are densely packed. In the middle zone, the fibers are oriented
more randomly but they start to orient in a more perpendicular manner to the
surface. Furthermore, in the deep zone, the fibres are arranged perpendicular to
the articular surface and the fibers are attached to the bone through the calcified
cartilage [19,23]. Additionally, to these zones, secondary collagen fibers are oriented
randomly throughout the cartilage. The collagen concentration decreases from the
deep zone to the middle zone and then increases again towards the surface [24].
PGs are proteins that are heavily glycosylated [25]. A PG monomer consist
of a core protein with one or more covalently bound glycosaminoglygan (GAG)
chains. GAG molecules are negatively charged due to their carboxyl and sulphate
groups, providing a negative fixed charge for the tissue [26]. This fixed charge inflicts
imbalance in osmotic pressure in the extracellular matrix. Consequently, water is
drawn into the extracellular space, causing the swelling of the tissue. This swelling is,
however, compensated by the collagen network of the cartilage resulting in swelling
pressure. Swelling pressure affects significantly to the mechanical properties of the
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cartilage, primarily to its compressive stiffness [14]. The PG concentration is highest
in the deep zone decreasing towards the cartilage surface [14,27].
Cartilage cells, chondrocytes, are highly differentiated cells that rely mainly on
anaerobic metabolism [28]. Healthy articular cartilage has only 1-5% of its volume
chondrocytes [23]. Chondrocytes attend to assembling and synthesis of cartilaginous
matrix components and their distribution within the tissue. Moreover, chondrocytes
can react to changes in the ECM by modifying the balance between anabolic and
catabolic reactions and by replacing the lost macromolecules due to tissue degener-
ation [29]. The activity of the chondrocytes decreases over time [30]. The activity
to synthesize collagen and PG also depends on the mechanical and physiochemical
properties of the environment [19].
In addition to providing lubrication, water maintains the transportation of nutri-
ents and ions across the articular surface to chondrocytes. Water can freely move in
and out from cartilage but a part of it is bound to the collagen fibers. The trans-
portation of water occurs through diffusion and convection owing to the avascular
structure of the cartilage. The flow of water affects the mechanical properties of the
tissue. Water contains also a high concentration of cations to balance the negative
fixed charge density caused by PGs. The water concentration is the highest in the
superficial zone and the lowest in the deep zone [19].
Joint motion and load are important for maintaining the normal articular car-
tilage structure and function. Inactivity of the joint can cause degeneration of the
cartilage [19]. There are two main mechanisms that ensure the minimal friction be-
tween articulating surfaces. Firstly, macromolecules, such as lubricin, in the synovial
fluid lubricate the surfaces [31]. Secondly, the interstitial fluid pressurizes during dy-
namical loading, thus forming a thin fluid film in the articulating surfaces decreasing
the friction [32]. Cartilage tissue can efficiently adapt itself to the prevailing loading
conditions owing to its porous and viscoelastic nature. During the mechanical load-
ing, the collagen network and increasing fluid pressure inside the cartilage control
the deformation by stiffening the cartilage. In static loading, cartilage softens while
water flows within and out from the cartilage enabling the loading to distribute to
the larger contact area.
Articular cartilage lacks blood vessels, lymphatics, or nerves [14]. Thus, the syn-
ovial fluid functions as the main source of nutrition for cartilage. The absence of
blood vessels, lymphatics, and nerves is also the main reason for the slow regenera-
tion of articular cartilage especially after mechanical injury. The unique and complex
structure of articular cartilage complicates the effective treatment and repair.
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2.2 Cartilage Injuries, Clinical Diagnostics and Treatment
Articular cartilage injuries of a knee are relatively common [33]. Damage to articular
cartilage is called a chondral injury or, if the underlying bone is also fractured, an
osteochondral injury [34]. Usually, a damage is a result of an accidental injury,
such as a fall, a sport injury, or any other source of a physical trauma. Acute
lesions caused by trauma, indirect impact loading, or torsional loading of a joint
are especially common in young, athletic adults. A injury of articular cartilage can
result in joint pain, swelling, loss of mobility, increased amount of synovial fluid,
and local tenderness in the injured area during the compression. Furthermore, other
joint injuries, such as meniscal lesions, often cause dominant symptoms as compared
to cartilage lesions. A articular cartilage injury can also initiate PTOA [35, 36].
PTOA is a type of joint disease in which articular cartilage degenerates gradually
and eventually depletes.
Due to limited capacity for self-repair, a focal damage can eventually lead to
complete degradation of the tissue. Thus, for effective treatment of the injury and
prevention of PTOA, early diagnostics of fresh cartilage degeneration is important.
Nevertheless, with the current diagnostic techniques that include MRI, clinical ex-
amination, native X-ray imaging, and arthroscopic examination, the detection of
cartilage degeneration is difficult or even infeasible since they can only detect late
and major tissue changes. For example, in MRI the resolution is limited and the
queuing times in hospitals are long while in native X-ray imaging cartilage is un-
visible since the attenuation of the cartilage and the surrounding soft tissue are
similar. However, contrast agent-based CT provides a promising tool for identifying
fresh cartilage injuries. CECT of a knee joint can be performed with a conical X-
ray beam to acquire images covering a large volume with a single rotation around
the knee. CECT imaging of a knee joint can be conducted using CBCT shown in
Fig. 2.2(a). As the natural contrast between the synovial fluid and cartilage on a na-
tive X-ray is almost indistinguishable, in CECT contrast agents are used to enhance
the interface of the synovial fluid and cartilage.
The earliest signs of cartilage damage are loss of PGs [38] and disruption of the
superficial collagen network [39,40]. They increase the permeability of tissue, thereby
affecting the diffusion of the contrast agent into articular cartilage [41, 42]. Thus,
fresh cartilage injuries can be detected by observing the changes in contrast agent
diffusion with the use of CECT [10,11]. Currently, two images are usually acquired
for the CECT of a knee joint: immediately after and at 45 minutes after contrast
agent injection into the synovial fluid. The first image (Fig. 2.2(b)(A)) is required
in segmentation of the cartilage as the contrast at the articular surface decreases
due to contrast agent diffusion into cartilage. Delayed imaging (Fig. 2.2(b)(B)) is
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(a) (b)
Figure 2.2: (a) A modern peripheral CBCT scanner (Verity, Planmed Oy, Helsinki) op-
timized for orthopedic imaging. (b) (A) Arthrographic images are acquired immediately
after the contrast agent injection highlighting the cartilage lesions. (B) Delayed images
acquired 45 minutes after the contrast agent injection, in addition to cartilage lesions,
highlighting also inferior cartilage integrity around the original lesion. (C) Images depict-
ing difference between the delayed and arthrographic images (i.e. contrast agent diffusion).
Detecting initiation of PTAO is possible based on these images. [37]
conducted usually at 45 minutes after administration since the maximum contrast
agent concentration in the cartilage is achieved at 30–60 minutes after the injection,
depending on the location in the joint and the contrast agent eﬄux from the knee
joint [37]. Delayed imaging is needed for the detection of cartilage injuries as the
contrast agent concentration at the injured or degenerated site elevates more as
compared to healthy tissue. Detecting PTOA is possible by depicting the differences
between the delayed and arthrographic images (Fig. 2.2(b)(C)).
If the cartilage injury is detected early enough, the development of PTOA could be
prevented by interventions since the cartilage lacks the ability to heal by itself. With
the current treatment of significant joint injuries, the risk of PTOA varies from about
20% to 50% [43]. Surgical interventions to repair cartilage injuries by stimulating the
growth of new cartilage have evolved during the past years. Bone marrow stimulation
is the most commonly used surgical technique to repair cartilage injuries [44]. In
bone marrow stimulation, multiple holes are made to the subchondral bone plate
so that the bone cells can enter from the bone marrow into to cartilage lesion.
These cells are then able to differentiate into fibrochondrocytes. Fibrochondrocytes
posses features of fibroblasts and chondrocytes; fibroblasts produce collagen I such as
fibroblasts and have a similar rounded morphology protected by a territorial matrix
as chondrocytes
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Surgical interventions also include autologous chondrocyte transplantation [45]
and autologous osteochondral mosaicplasty [46]. Autologous chondrocyte trans-
plantation is conducted in three stages to restore the hyaline cartilage at the repair
site. In the first stage, cartilage samples are harvested arthroscopically from a less
weight bearing area. Then, cartilage cells are grown in vitro and finally injected
into the lesion under a periosteal flap sutured to cartilage to cover the lesion. A
autologous osteochondral mosaicplasty requires only one operation. The operation
involves obtaining multiple small cylindrical osteochondral grafts from a less weight
bearing area and transplanting them into the cartilage lesion. In addition to surgical
intervention, pharmaceutical interventions can be used to prevent the development
of PTOA [4,5].
93. CONTRAST ENHANCED COMPUTED
TOMOGRAPHY
In this chapter the concepts of CECT of articular cartilage are discussed. The
chapter is began by introducing the basics of X-ray CT. Then, the contrast agents
used to highlight specific structures in the joint are introduced and moreover, the
physics of contrast agent diffusion into cartilage is described. Finally, we review the
basic idea behind CECT.
3.1 X-ray Computed Tomography
X-ray CT is an imaging technique used in medicine, as well as industrial applications,
for visualizing interior features within solid objects and for obtaining 3D images to
study their geometries and properties [47, 48]. Tomography refers to a technique in
which imaging is done in sections or by sectioning through the use of penetrating
waves such as X-rays. The concepts of X-ray CT are discussed in this section based
on the references [49–51] unless mentioned otherwise.
X-radiation
X-radiation, is a form of electromagnetic radiation composed of X-rays with the
wavelength of 0.01 to 10 nanometers and energies varying from 100 eV to 100 keV.
X-radiation is harmful for living cells because high-energy X-ray photons are able to
ionize atoms and disrupt molecular bonds. A extremely high radiation dose received
in a short amount of time causes radiation sickness while a lower doses increases the
risk of radiation-related cancers. Nevertheless, cancer treatments are based on the
ionizing capability of X-rays and their capability to kill malignant cells.
X-rays with high energies (5-10 keV) are called hard X-rays, while X-rays with
lower energy are called soft X-rays [52]. Since soft X-rays have low energy they are
easily absorbed by air and by other mediums. Hard X-rays, on the other hand, can
traverse relatively thick objects without being much absorbed or scattered; therefore,
hard X-rays are widely used in imaging, e.g. in medical radiography or in industrial
radiography.
Production
X-rays are produced in an X-ray tube by accelerating electrons with a high voltage
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Figure 3.1: A schematic representation of an X-ray tube. In the X-ray tube, the electron
beam is generated by heating the cathode. The electron beam is rapidly accelerated with
a high voltage against the anode in vacuum, and upon colliding with the anode, a beam of
X-rays is generated and emitted throught the window designed for escape of the generated
X-ray photons.
and allowing them to collide with a metal target. Fig. 3.1 shows a schematic repre-
sentation of an X-ray tube. In the X-ray tube, thermionic emission causes the release
of electrons when the cathode is heated. The emitted electrons are accelerated by
a high voltage towards the anode, which is positively charged relative to the cath-
ode. Operating acceleration voltages of modern clinical CT scanners vary among
different scanners but generally fall between 80 and 150 kVp. Here, peak kilovoltage
(kVp) refers to the maximum voltage applied across an X-ray tube determining the
kinetic energy of the accelerated electrons in the X-ray tube and the peak energy
of the X-ray emission spectrum. The electrons accelerated by this high voltage are
referred to as projectile electrons. A vacuum is required inside the X-ray tube to
prevent the projectile electrons from interacting with the air molecules. Without
vacuum, the projectile electrons will loose their energy in collisions before reaching
the anode.
Two types of X-rays are created when the projectile electrons hit the anode.
Brehmsstrahlung X-rays or ”braking radiation” are released when the accelerated
projectile electrons hit the anode and decelerate as they collide with the electrons in
the metal. As the projectile electrons decelerate, they lose their kinetic energy which
is converted to electromagnetic radiation, in this case, to X-rays with wavelengths
between 0.01 and 10 nm. The closeness of approach of the projectile electron to
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Figure 3.2: The X-ray energy spectrum. The effect of filtering can be seen as loss of low
energy photons. Modified from [53].
the target nucleus affects the amount of energy radiated. Thus, the energy of the
brehmsstrahlung X-rays vary from 0 up to maximum energy equal to the energy
of the projectile electrons which numerically corresponds the accelerating electrical
potential.
The other type of X-rays produced in an X-ray tube are characteristic X-rays.
They are created as the bombarding projectile electrons with sufficient energy excite
an electron of a target metal atom. When the electrons from higher states fill
the vacancies, X-ray photons are emitted with precise energies determined by the
electron energy levels. As a result of different electron energy levels in metal atoms
of which the electrons of a target metals atoms can excite, characteristic X-rays are
monoenergetic. The X-ray energy spectrum generated by the X-ray tube is presented
in Fig. 3.2.
Generally, projectile electrons never lose their energy in one interaction. Projectile
electrons collide with multiple atoms in the anode; therefore, due to these collisions
only one percent of the electron beam energy is converted to photons while the rest
is converted to heat. To get rid of the heat, a large anode can be used to absorb the
heat but this mechanism is based on the conduction in the metal anode. Typically,
the conduction in the anode is excessively slow resulting in melting of the anode
material. To avoid melting, the anode is rotated, thus continuously exposing a new
surface to the electron beam and enabling the rest of the anode to cool down before
it rotates back to the position of the beam of electrons.
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Clinical CT scanner
A clinical CT scanner consists of an X-ray tube and a detector that are diametrically
attached to a big turning gantry which can spin around a patient. During the scan,
the patient is lying on a table that is attached to the CT scanner and moving trough
the gantry while the gantry is rotating around the patient. This allows X-rays pass
through the patient in different angles so that each rotation of the gantry yields
several images of thin slices of the patients’ body. The time needed for the scan
varies between different types of the scan; however, most scans are completed in
ten to fifteen seconds. After the scan, computer reconstructs a detailed image of
structures inside the body.
X-ray attenuation and interaction with matter
X-ray image is created as a X-ray beam passes through the body section project-
ing an image onto a detector. X-ray imaging is based on the variable attenuation
of X-rays in different tissues. Attenuation is the reduction of the intensity of an
X-ray travelling in medium. Attenuation of the X-ray depends on the penetrating
characteristics of the beam and the physical properties of the tissues. As an elec-
tromagnetic radiation and by assuming that the X-rays are monoenergetic, X-rays
attenuate exponentially by according to the equation:
I(x) = I0e
−µx, (3.1)
where I is the intensity of the radiation, I0 the initial intensity of the radiation, µ
the linear attenuation coefficient, and x the distance travelled in the medium. A
linear attenuation coefficient, on the other hand, describes the fraction of radiation
attenuated in a given thickness of a absorber:
µ =
∆N
N∆x
, (3.2)
where N is the total amount of photons and ∆N the number of photons removed
from the X-ray beam in thickness ∆x. A linear attenuation coefficient depends
on the energy of the radiation, the number of photons traversing the attenuating
medium or absorber, atomic number of the absorber, and the electron density of the
absorber [54].
In the medium in the diagnostic range below 200 keV, the attenuation is due
to three dominate interactions: elastic scattering (Rayleigh scattering), Compton
scattering, and photoelectric absorption. Rayleigh scattering is the dispersion of X-
radiation by particles that have radius less than approximately tenth the wavelength
of the X-radiation. In Rayleigh scattering, the photons interact with the medium
and are then re-emitted at the same wavelength in a different direction. Rayleigh
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scattering contributes more on very high atomic number (Z) material than for low
Z materials [55].
Compton scattering describes an inelastic collision of a photon and a free electron
or a loosely bound electron in an outer shell. The collision results in a decreased
energy of the photon (Compton effect). The lost energy is transferred to the recoiling
electron as kinetic energy. In addition, in inverse Compton scattering, a charged
particle transfers part of its energy to a photon. Compton scattering dominates for
high energies and low Z.
In photoelectric absorption, a photon interacts with an electron and transfers all
of its energy to the electron. The atom to which the electron was bound is ionized,
thus producing a photoelectron which is then able to ionize more atoms in its path.
The kinetic energy of the ejected electron is dissipated in the material. The vacant
electron position will be replaced by other electron from the outer electron orbital,
producing either a characteristic photon or an Auger electron with the energy that
equals the energy difference of the two orbitals. X-ray spectroscopy or Auger electron
spectroscopy utilize these photoelectric effects in elemental detection. As the binding
energies in high Z materials are closer to X-ray energies, the electrons in high Z
materials are more likely to be involved in photoelectric absorption.
Reconstruction
Once the attenuated X-ray beam have traversed through a patient, it interacts with
the detector that measures the number of electrons that have passed the patient,
practically the intensity of the attenuated X-ray beam. The most commonly used
detectors in CT scanners are scintillator-photodiode solid state detectors. When the
X-rays reach the scintillator visible light is produced. This light is then converted
to an electric current by the photodiode. Finally, the information is send to the
computer which analyses the information received by the X-rays and constructs a
image of a slice of a body.
The image is reconstructed mathematically from a large number of one-dimensional
projection data acquired at many different angles around the patient. Currently, two
types of algorithms are used in reconstructing images: analytical and iterative algo-
rithms [56].
The most commonly used analytical algorithm is the filtered back-projection
method. Filtered back-projection is based on a simple back-projection method in
which the measured attenuation profiles from different direction are simply projected
across the image plane (Fig. 3.3(a)). The resulting image in simple back-projection
is a blurred version of the object. In filtered back-projection, the blurriness of the
image (start-like artefacts, Fig. 3.3(b)) can be removed by convolving the attenua-
tion profile with a negative wing filter function, illustrated in Fig. 3.3(c), prior to the
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Figure 3.3: An illustration of simple back-projection and filtered back-projection. (a) In
simple back-projection, (b) attenuation profiles from different direction are simply pro-
jected across the image plane. However, in filtered back-projection, (c) the attenuation
profiles are first convolved with a filter function and (d) then back-projected. The illus-
tration is modified from [49].
back-projection. Introducing these negative wings results an accurate representation
of the original object (Fig. 3.3(d)). In addition to accuracy of the method, the image
reconstruction of the filtered back-projection is fast. Filtered back-projection pro-
vides fast image reconstruction since the projections can be preprocessed, filtered,
and then back-projected as soon as the first set of measurements are made by the
X-ray detectors.
Iterative image reconstruction forms images from projection of an object using
iterative algorithms. Iterative image reconstruction is usually considered better but
computationally a more expensive alternative to the filtered back-projection method.
In iterative image reconstruction, there is a large variety of algorithms available but
the basic idea behind the algorithms is the same. First, each algorithm will start
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Figure 3.4: A schematic representation of attenuation profiles of voxels.
with an assumed image and computes the projection from that image. Then, the
algorithm compares the projection to the original projection data and updates the
image based on the differences between the calculated and the actual projections.
In that way, the algorithm approaches the correct solution using multiple iterations
step by step.
Using one of the reconstruction methods, computer separates the body into small
volumes called voxels (3-dimensional pixel). Every organ consists of millions of
voxels and each voxel is given a number which represents the extent to which X-rays
are attenuated when they pass through the organ. For example, a piece of bone has
a very high voxel value because of the strong X-rays attenuation of the bone but for
skin the voxel value is low because the skin does not absorb the X-rays as much.
The depth information along the direction of the X-ray beam is lost in radio-
graphy but it can be achieved by viewing the slice from many directions. X-ray
beam traversing from one side of the patient to another attenuates according to
equation (3.1) by all of the voxels through which it passes. Thus, the X-ray beam
has an intensity I as follows:
I(x) = I0e
−x
n∑
i=1
µi
, (3.3)
where n is the number of a voxel. This equation shows that the X-ray intensity can
be expressed as a sum of the attenuation coefficients of the voxels in the path of
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X-ray beam, as illustrated in Fig. 3.4. By rearranging this equation as
ln
I0
I
= x
n∑
i=1
µi, (3.4)
it is clear that the natural logarithm of the ratio of incident to transmitted X-
ray intensities are proportional to the sum of the attenuation coefficients of the
voxels in the path of the beam. However, the X-rays produced in the X-ray tube
are polyenergic, the equation (3.4) becomes an approximation. Furthermore, beam
hardening effect, described later, can lead to an underestimation of the voxel values
in the image.
For the image viewing purposes, CT scanner converts the measured attenuation
coefficients of the voxels into to CT numbers called Hounsfield units (HUs). Thus,
CT number describes the density assigned to a voxel. CT number is a normalized
value of the calculated X-ray absorption coefficient so that the density for air is
-1000 HU, for water 0 HU, and for compact bone approximately +1000 HU. Most
of the human soft tissue have a CT number in the range of -100 – +100 HU. The
CT number Ci for a voxel i can be calculated as
Ci = 1000× µi − µw
µw
, (3.5)
where µi is the attenuation coefficient of the tissue in the voxel and µi the attenuation
coefficient of water. The scaling factor of 1000 in the equation is used to express
the CT numbers in integers. Utilization of integers reduces computer memory and
storage requirements.
In this way, a CT scanner can produce a digital image that makes it possible
to look at the body in different angles and scroll thought the body to look certain
areas. CT images are usually viewed as grayscale images, and the contrast between
different tissues can be further enhanced by windowing the image between certain
values. Usually, the range of available grey-levels are limited to better correspond the
tissue studied rather than allocating the full range of CT numbers. Voxels outside
of the selected range, appear either as pure white or pure black.
Artifacts
There are many different kind of artifacts in CT, including noise, beam hardening,
scatter, motion, cone beam, helical, ring, partial volume effect, and metal arti-
facts [57]. Artifacts can obscure the image and, in the worst case, even simulate
pathology.
Noise is caused by statistical error of low photon counts. Noise can be seen as
random thin bright and dark streaks appearing preferentially along the direction of
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Figure 3.5: (a) A CT-guided biopsy with extensive noise artifact (b) A simulated CT scan
showing the beam hardening effect: dark streaks are occuring along the lines of greatest
attenuation surrounded by bright streaks in both sides. Figures modified from [57].
the greatest attenuation (Fig. 3.5(a)). Noise affects less on high attenuation objects
(e.g. bone) as the boundaries of low attenuation objects (e.g. soft tissue) can be
obscured. Iterative reconstruction or performing multiple scans to combine data is
used to reduce noise artifacts.
In CT images, beam hardening and scatter appear as dark streaks surrounded
by bright streaks adjacent to the dark streak between two high attenuation objects,
including bone, metal, and iodinated contrast agents (Fig. 3.5(b)). Beam hardening
is observed as an increased high energy photon content in the X-ray beam when
the lower energy photons are attenuated more easily as the beam passes through
the object. Therefore, unlike monocromatic X-ray, the beam transmission differs
from the simple exponential decay. Beam hardening causes the edges of an object
to appear brighter than the center despite the material is the same throughout.
Compton scatter, on the other hand in the cone beam geometry, obscures CT images
by causing the X-ray photons to change direction. In fan beam geometry Compton
scattering actually improves the image quality. These photons may then end up in a
different detector causing wrong interpretation. Using higher kV causes higher X-ray
beam, thus decreasing the beam hardening effect and scatter artifacts. Furthermore,
iterative reconstruction reduces both beam hardening and scatter. Beam hardening
can also be reduced by using a dual energy CT.
Patient movement, respiration, or cardiac and bowel movements results in blur-
ring, double images, and long range streaks in a CT image (Fig. 3.6(b)). Motion
artifacts can be minimized by using a faster acquisition time during which the patient
has less time to move. Moreover, some scanners have special features to minimize
the artifacts resulting from the motion of the patient.
Helical and cone beam artifacts are related to the scaning geometry. Even though
3. Contrast Enhanced Computed Tomography 18
Figure 3.6: (a) A cone beam CT image of prostate patient illustrating the behaviour of
streak artifact. Figure modified from [58]. (b) A CT image of the head showing motion
artifact, modified from [57]. (c) A simulated CT scan showing illustrating helical artifact,
modified from [59]. (d) Ring artifacts around a water-filled phantom, modified from [59].
helical multidetector row and cone beam CTs can reduce artifacts caused by motion,
they also have some additional artifacts. For example, as the detector rows in helical
CT pass by the axial plane of the object, the reconstruction alternates between
conducting measurements from a single detector row and interpolating between two
detector rows. Thus, in the case of a high contrast edge between the two detector
rows, the interpolated value may be inaccurate. This causes smooth periodic dark
and light streaks to form a windmill-like artifacts originated from the high contrast
edge (helical artifact). Furthermore, in multidetector row CT, high contrast edges
in z direction between the axial plane and the projection plane creates streaks (cone
beam artifact (Fig. 3.6(c)). This effects intensifies as the number of detector rows
increase. Cone beam artifacts can be reduced by using a Adaptive Multiple Plane
Reconstruction (AMPR) [60] or cone-beam reconstructions.
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Ring artifacts occur when a detector element is miscalibrated or defective. In CT
images, ring artifact appears as rings centered on the center rotation (Fig. 3.6(d))
and can usually be fixed by recalibrating the detector or by replacing it [61]. Ring
artifacts are seldom confused with disease, but can impair the diagnostic quality of
an image.
Partial volume effect is a combination of two factors: limited resolution of a imag-
ing system and image sampling. Each voxel represents the attenuation properties of
a tissue. If that voxel comprises many different tissues, the CT number of that voxel
represents some average of their properties. Thus, partial volume effect causing the
blurriness of image. Partial volume effect can be reduces using a higher resolution,
but this usually prolong the acquisition times. Also partial volume correction is used
to minimize the partial volume effect.
Metal artifacts are remarkably common and are due to multiple other artifacts,
including beam hardening, scatter, noise, motion, and edge effect related to metal
itself or to the metal edges. Metal artifacts are particularly associated with high
atomic number metals, such as iron or platinum. Metal artifacts can be avoided by
placing the object so that the gantry tilt can angle the metal outside of the axial
slices of interest. Iterative reconstruction also helps to reduce metal artifacts.
Image quality control
Filtration is used to reduce the intensity of the X-ray beam, to decrease patient
exposure, and to improve image quality for a given radiation dose. The total fil-
tration of the X-ray beam is a mixture of inherent filtration, caused by X-ray tube
itself and housing material, and added filtration. Added filtration is a thin sheets
of a metal inserted in the X-ray beam. The most commonly used filter materials
are copper, aluminium, lead, and brass that are all high atomic number materials.
Radiation, emitted by the X-ray tube, is poly-chromatic; thus, filtering helps to
reduce the unwanted X-ray energies by removing the long-wavelength X-rays, soft
X-rays. Elimination of the soft X-rays reduces the patients’ radiation doses since
these long-wavelength X-rays are not contributing to the CT image as they absorb
fully into patient. The use of filters also produces a cleaner image by absorbing the
lower energy X-ray photons that tend to scatter more as compared to higher energy
X-rays. Moreover, a more uniform beam improves the image quality by reducing
artifacts caused by beam hardening.
Usage of collimators also improve the CT image quality and reduce unnecessary
doses to patient. Collimators are located immediately in front of the detectors
protecting them from scattered X-rays. Their purpose is to filter the X-ray beam
so that only X-ray that are parallel to a specified direction are allowed through.
Even though collimators improve resolution, they also hinder incoming radiation by
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reducing the intensity and, therefore, also the radiation dose.
X-ray computed tomography devices
CT is one of the most commonly used non-invasive imaging modalities in clinical
use due to its wide availability, high efficiency, low cost, and the development of
novel hybrid imaging systems. There are many different types of CT devices varying
from micrometer-scale preclinical scanner and peripheral quantitative CT (pQCT)
to full body instruments with different sampling geometries, as well as dual-energy
CT with both single- and dual-source scanners. The sampling geometries include
fan beam and cone beam. Spiral CT scanners use a fan-shaped X-ray beam in a
helical progression to acquire individual image slices. Here, we will only review the
basic idea behind the cone-beam geometry and microCT, used in this study, in more
detail.
Cone-beam computed tomography (CBCT) utilizes a divergent pyramidal- or
cone-shaped beam to acquire images with a single rotation around the patient. The
cone-beam geometry was initially designed as an alternative to conventional CT
using either fan-beam or spiral-scan geometries. The advantage of the cone-beam
geometry is faster acquisition of a data set and comparatively less expensive radi-
ation detector. In addition, CBCT provides shorter examination time, including
the reduction of image distortion due to internal patient movements, and increased
X-ray tube efficiency [62]. Compared for example with spiral CT, the advantage of
CBCT is its lower radiation doses [63–65]. However, a limitation of image quality
related to noise and contrast resolution due to large amounts of scattered radiation
detected is a main disadvantage of the cone-beam geometry. CBCT is commonly
used in dental imaging because it allows the acquisition of high resolution isotropic
image stacks [66].
High resolution microCT is a laboratory equipment that allows the imaging of
small objects. It also uses X-rays to generate 3D image of a physical object. It is
unsuitable for clinical use. The prefix micro- (µ) indicates that the pixel size is in
the micrometer range. With microCT, only small objects (diam < 1 cm) can be
imaged to obtain the maximal resolution. With larger object sizes, due to applied
imaging geometry, the image resolution is reduced.
In microCT imaging, in contrast to the clinical CT, the object is usually rotated
while the X-ray source and detector are kept stationary. The cone-shaped X-ray
beam is magnified before reaching the detector to create magnified image of the
object. This is achieved by placing the object closer to the X-ray source, away from
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the detector. The magnification M can be calculated from the equation
M =
L
′
L
=
dos + dod
dos
, (3.6)
where L
′
is the magnified object size, L the original object size, dos the distance
between source and object, and dod the distance between the object and the detector.
CT imaging enables the detection of smaller differences in attenuation coeffi-
cients; thus, the contrast of CT image is higher compared to a native X-ray image.
However, in CT, the maximum resolution is lower than in a native X-ray imag-
ing. The difference of 0.44 % in linear attenuation coefficients can be detected in
clinical CT-scanners. Nevertheless, objects less than 0.5 mm apart are difficult to
distinguish [67].
Medical uses
Based on the frequency of use and hospital availability, CT is one of the most preva-
lent diagnostic tools in modern medicine [68, 69]. X-ray CT provides high contrast
images with depth information; images can be viewed in the axial, coronal, or sagit-
tal planes, depending on the diagnostic task. Thus, X-ray CT is routinely used in
diagnosis in radiology, and moreover, it is a useful tool in radiotherapy treatment
planning, prosthesis design, craniofacial reconstruction, stereotactic biopsy planning,
and 3D imaging for surgical planning. Furthermore, CT imaging is less expensive,
less time consuming, and more readily available compared to other medical imag-
ing technologies such as magnetic resonance imaging (MRI) and positron emission
tomography (PET). In clinical use, CT procedure typically takes approximately 30
minutes including the injection of a contrast agent, the positioning of the patient
and the imaging. CT can also be used in the detection of fast motion, such as
cardiac motion, due to its high temporal resolution [70, 71]. Finally, owing to the
development of novel hybrid imaging systems such as PET/CT and single-photon
emission tomography (SPECT)/CT, the CT has a great impact on clinical medicine
today.
3.2 Contrast Agents
Many tissues can be easily visualized using CT imaging. However, the attenuations
of X-ray radiation for different soft tissues, including cartilage, are quite similar.
Hence, exogenous contrast imaging agents are used to enhance the contrast and
improve the visualization between tissues by increasing the absolute CT attenuation
differences between the target tissue and the surrounding tissue as well as fluids [72].
Contrast agents are administered either intravenously or directly injected into the
area of interest.
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Contrast agents with high Z or high density (ρ) tend to be the best for highlighting
desired structures in the body [73]. The relationship can be expressed in the formula
for X-ray attenuation coefficient (µ) as follows:
µ =
ρZ4
AE3
, (3.7)
where A is the atomic mass and E the X-ray energy. The reason behind the relation
between the high atomic number and attenuation coefficient is photoelectric effect.
Photoelectric effect is proportional to the third power of the atomic number of the
material (Z3) and for good contrast images the selection of high atomic number
materials is prominent.
In the design of CT contrast agent for clinical application, several requirements
need to be considered [73,74]. Firstly, the optimal CT contrast agent should provide
maximum imaging capabilities. By increasing the attenuation between the target
tissue and its surrounding tissue and fluids at least by a factor of two, contrast agent
can drastically improve the visualization of the tissue under examination. Secondly,
the contrast agent should be readily transferred to patient. Thus, it should form
a stable suspension or be soluble at aqueous physiological conditions e.g. it should
have proper pH, osmolality, and low viscosity. Thirdly, the contrast agent should
be able to localize the target tissue and posses a favourable biodistribution and
pharmacokinetic profiles. Fourthly, the contrast agent and its metabolises should be
non-toxic and they should be excreted from the body within the reasonable amount
of time (<24 h). However, the retention time of the contrast agent should be long
enough for completion of the CT scan (2–4 h) [73]. Finally, the production of CT
contrast agent costs should be low and furthermore, the resulting compound should
also be stable chemically and as heated.
Iodine-based contrast agents are the most commonly used contrast agents in X-
ray imaging due to the high atomic number of iodine (Z = 53) [75]. Furthermore,
iodinated contrast agents have good solubility and low toxicity due to their functional
groups [51]. For example, carboxylic acids and amines attached to the iodinated
aromatic ring increase biocompatibility and water solubility of iodinated contrast
agents [76]. Furthermore, iodine has a k-edge of 33.2 keV which is suitable for
clinical use since the k-edge is close to the mean energy of most diagnostic X-ray
beams. K-edge is the binding energy of the K shell electron of a material. The
attenuation coefficient of the photons having a energy just above the k-edge increase
substantially compared to photons with an enetgy just above the k-edge. Iodine-
based contrast agents are usually classified as ionic or non-ionic (organic compound)
based on the compound iodine is attached [74]. Ionic contrast agents were developed
first but the major disadvantage is that they may result in additional complication
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making the introduction of ionic contrast agents difficult for further clinical practice.
Despite of this issue, they are still in widespread use depending on the requirements.
Non-ionic contrast agents were developed to decrease the possibility of side effects as
they covalently bind the iodine and remain undissociated into component molecules.
In addition, the advantage of non-ionic over ionic contrast agents is their lower
osmolality.
Although iodine-based contrast agents are very convenient in many clinical imag-
ing cravings, the rapid renal clearance restricts imaging applications that require
long circulation times. In addition, iodine-based contrast agents sometimes induce
serious adverse effects related to the excretion pathway [76]. Lastly, for clinical CT
using high-energy X-ray, the attenuation of the iodine is insufficient. To overcome
these limitation, nano-sized CT contrast agents have been developed to increase the
circulation time and to decrease the undesirable effects.
Recently nano-sized, metallic contrast agents have gained attention as X-ray
contrast agents due to their high density and high atomic numbers, thus possess-
ing favourable X-ray attenuation properties [77]. For example, gold nanoparticles
(AuNPs) have already been extensively studied as gold provides about 2.7 times
greater contrast per unit weight than iodine [78]. Furthermore, AuNPs exhibit low
toxicity, facile synthesis, surface functionalization for colloidal stability, and good
target delivery [77]. However, AuNPs are expensive and hence the clinical applica-
tion might cause problems. Thus, in addition to AuNPs, other nanoparticles based
on heavy atoms such as lanthanide, tantalum, and bismuth are used as more efficient
CT contrast agents.
Inorganic nanoparticles are usually coated by an organic capping layer since
nanoparticles are generally unstable owing to their high surface energy and to
improve their physicochemical properties. Moreover, nanoparticles also aggregate
often due to high ionic strength of many biological fluids [79]. The organic cap-
ping layer provides a protective coating, compatible with the solvent, and prevents
nanoparticles for aggregating by counteracting the attracting forces occurring be-
tween nanoparticles. The coating layer prevents particle surfaces coming into close
contact by steric repulsions between the polymer layers. With this separation the van
der Waals forces are too weak to cause particles to adhere. TWEEN 80 (polysorbate
80) and polyethylene glycol (PEG) are one of the most commonly used polymers
used for coating. In addition to coating polymers, surface of the nanoparticles can be
modified to reach certain special features. For example, modification can be used to
improve the interactions between the inorganic nanoparticles and the coating poly-
mer [80]. Additionally, the surface can be modified to change the surface charge of
the nanoparticle to for example generate a strong repulsion between nanoparticles.
Bismuth nanoparticles (BiNPs) have been studied as a possible contrast agent due
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to their high X-ray attenuation coefficient, cost effectiveness, and low toxicity [73].
As compared to iodine, bismuth (Z=83) has greater X-ray attenuation intensity
owing to its higher atomic number and electron density. In addition, an inorganic
nanoparticle provides many advantages, such as longer circulation and retention
times, lower administration volumes, and greater potential for site directed imag-
ing, over more widely used intravascular contrast agents. Bismuth has already been
widely used as an ingredient in pharmaceuticals and cosmetics. Furthermore, bis-
muth(III) salts, such as bismuth oxide, have been used in therapy without showing
adverse side effects [13]. As a contrast agent for CT, studies suggest that bismuth-
based nanoparticles are efficient dose enhancing agents, and they comprise a great
potential in radiotherapy [81].
The challenge of designing new nano-sized contrast agents is the low sensitivity of
CT. For example, successful CT requires millimolar concentrations of contrast agents
while MRI can detect micromolar concentrations [82]. In typical clinical scanner,
the noise level varies from one to three HU; thus, for example a lesion with five to ten
HU is detectable. With approximately of 0.5 mg/ml of gold nanoparticles the same
contrast can be produced but this concentration is very high compared with many
molecular targets expressed in the nanomolar range [83]. Furthermore, most of the
nano-sized contrast agents effective for X-ray attenuation have high atomic weights,
and most of them are very toxic. Despite these challenges, new nanoparticles have
already prolonged circulation times, and the possibility of engineering them for bet-
ter delivery to target tissue has demonstrated their enormous potential [84,85].
3.3 Contrast Agent Diffusion in Cartilage
Due to avascular and porous structure of the cartilage, nutrients, and for exam-
ple contrast agents are transported into cartilage via diffusion [23]. Diffusion is a
molecular movement from a region of high concentration to a region of low concen-
tration until the concentration gradient disappears. Diffusion is a dominant form
of material transport on sub-micron scales [86]. Diffusion is essentially a question
of random fluctuations in the tissue called Brownian motion. Brownian motion is
the random movement of the particles in a fluid, thus constantly undergoing small,
random fluctuation. The movement of molecules in the cartilage and synovial fluid
can be described with Fick’s laws of diffusion [87].
The Fick’s first law applies only when the system under examination is assumed
to be in steady state. The diffusion flux J is the rate of the net movement of the
molecules across a unit area, and it is directly proportional to the concentration
gradient. The diffusion flux can be expressed according to Fick’s first law as follows:
J = −D∂C
∂x
, (3.8)
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where D is the diffusion coefficient, C the concentration, and x the position along
the tissue depth. The diffusion coefficient describes the time needed for a particular
solute to move through a particular tissue, and it is a specific constant for the solute
of interest and the tissue through which the solute is transported.
The Fick’s second law called diffusion law relates the diffusion flux to the concen-
tration when the diffusion flux is time varying. The diffusion flux of contrast agent
through the tissue surface in a time dependent case is directly proportional to the
concentration gradient, which is always directed towards the lower concentration.
The diffusion flux through cartilage surface can be written as
∂C
∂t
= D
∂2C
∂x2
, (3.9)
where t is the time. The diffusion flux is always directed towards the lower concen-
tration.
The Gibbs-Donnan equilibrium is a state of equilibrium between two solution
containing electrolytes, the ions separated by semi-permeable membrane [86, p. 414].
The distribution of the confined ions in the two solutions cause an electrical potential
across the membrane. This potential causes the ions to distribute unevenly across
the membrane after the equilibrium for both concentration and electrical charge
distribution is reached. At the equilibrium state, Nernst equation gives the ion
distribution across the membrane when the gradient of the potential is similar for
all the species of the ion. According the Nernst equation, the membrane potential
∆Ψ can be expressed as
∆Ψ = −RT
zF
ln
[C]1
[C]2
, (3.10)
where R is the gas constant, T the temperature, z the valence of the ion, F Fara-
day constant, [C]1 the concentration on one side of the membrane, and [C]2 the
concentration on the other side. By rearranging this, we get
r =
(
[C]1
[C]2
)1/z
, (3.11)
which is know as a Donnan ratio. Now, the membrane potential can be achieved by
combining the Nernst equation and Donnan ratio as
∆Ψ = −RT
F
ln r. (3.12)
This implies that the presence of a fixed charge generates an osmotic gradient across
the membrane [88].
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To simplify the discussion, three species of small ions Na+, K+, and Cl− are con-
sidered with concentrations of ci. On the side 2 of the membrane, KCl is completely
dissolved at concentration C2, and on the side 1, NaR is completely dissolved at
concentration C1. Here, R
− refers to a generic non-mobile ion which is unable to
move from other side of the membrane to other. If some Na+ are imported to the
other side of the membrane, at the same time some K+ need to be expelled or some
CL− imported as electronegativity must remain unchanged. Thus, one can state
that z = x − y. Using the equation 3.11, the following group of equations can be
formed as
c1,Na+
c2,Na+
=
c1,K+
c2,K+
=
c2,Cl−
c1,Cl−
⇒ C1 − (x− y)1
x− y2 =
x1
C2 − x2 =
C2 − y2
y1
. (3.13)
By reducing this to x+ y = c2 and by solving the equatin in term of x, y and z, we
get
x =
(C1 + C2)C2
C1 + 2C2
, y =
C22
C1 + 2C2
, z =
C1C2
C1 + 2C2
. (3.14)
Finally, the Donnan ratio can be presented as Gibbs-Donnan relations:
c1,Na+
c2,Na+
=
c1,K+
c2,K+
=
c2,Cl−
c1,Cl−
in equilibrium. (3.15)
Now, it is clear that the fixed charge on one side of the membrane distributes the
mobile ions unevenly on both sides of the membrane [88]. Finally, the Donnan ratio
r can be presented as
r =
[Na+]1
[Na+]2
=
[K+]1
[K+]2
=
[Cl−]2
[Cl−]1
=
c1 + c2
c2
. (3.16)
The distribution and the concentration of mobile ions in articular cartilage is
affected by the fixed charge in the extracellular matrix [89]. Thus, applying above
described theory to cartilage tissue, the interactions between mobile ions and fixed
charge density can be defined with the Gibbs-Donnan theory [90]. On the other
hand, we can assume that the distribution of mobile ion can be expressed using
Donnan equilibrium (eq. 3.16) since negatively charged GAG-molecules are effec-
tively bound to the extracellular matrix. Now, assuming ideal Donnan conditions
and taking the charge of the ions into account, the equilibrium in cartilage can be
written as [91] (
[cation]bath
[cation]cartilage
)zcation
=
(
[anion]bath
[anion]cartilage
)zanion
. (3.17)
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(a) Coronal view (b) Sagittal view
Figure 3.7: CECT image of a knee immediately after the contrast agent administration.
Left-hand image is showing the knee in front (coronal) while right-hand image is from the
side (sagittal). Injected contrast agent is the brightest area in the picture highlighting the
synovial fluid.
Here, it is good to notice that cartilage is assumed to be externally electroneutral,
and thus
zcation · ccartilagecation = zanion · ccartilageanion + FCD, (3.18)
where FCD refers to fixed charge density of the cartilage caused by GAG-molecules [26].
The structural and compositional features of the cartilage affect the contrast agent
diffusion. The diffusion coefficient varies between the different layers of articular
cartilage based on collagen and PG concentration as well as the water content. For
example, a high collagen content of the deep cartilage is hypothezised to create
a steric hindrance to the penetration of the contrast agent [92, 93]. PG content,
conversely, may either increase or decrease or may have no affect at all for contrast
agent diffusion depending on the contrast agent [94]. Furthermore, the increase
in the molecule size decreases the diffusion rate into cartilage [95]. On the other
hand, steric interaction between diffusing molecules and cartilage may either increase
or decrease the diffusion. Finally, the charge of the contrast agent changes the
equilibrium partition; an anion, that has a greater negative charge, has a lower
equilibrium partition than an anion with lower charge [96].
3.4 Contrast Enhanced Computed Tomography of the Knee Joint
X-ray arthrography utilizes X-rays to acquire a series of pictures of a joint after in-
jection of a contrast agent, and it has been in clinical use for decades [97–99]. X-ray
arthrography allows the detection of superficial lesions as well as the detection of
different soft tissue structures of the joint including tendons, ligaments, muscles, car-
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tilage, and the joint capsule [100,101]. The visibility of these structures requires the
presence of contrast agent since they are invisible on a plain X-ray without contrast
agent. Furthermore, the natural contrast between the synovial fluid and cartilage is
almost indistinguishable in the knee join. Contrast enhanced computed tomography
(CECT) can overcome these limitations. Thus, CECT have been proposed as an
effective tool for the detection of lesions in articular cartilage in clinical practice [10].
In CECT examination, contrast agents are used in CT to enhance the contrast
between the tissue of interest and the surrounding structures. The CECT imaging of
knee joint can be conducted before, immediately after, and at 45 minutes after con-
trast agent injection to the synovial fluid. The before and immediately after images
provide an baseline of the cartilage (Fig. 3.7). Generally, these images are needed
for the segmentation of the knee structures from CECT images. The segmentation
in later stages of the CECT is impossible with the use of current contrast agents in
the market due to their diffusive properties.
Immediately after the contrast agent administration into synovial fluid, the con-
trast agent starts to diffuse into the articular cartilage. In the iodine-based contrast
agent case, the anionic contrast agent distributes in inverse proportion in the carti-
lage that is negatively charged due to highly negatively charged PGs. Additionally,
several in vitro studies also suggest high correlation in anionic contrast agent concen-
tration and GAG concentration in cartilage due to diffusion [41,42,102–104]. After
30 to 60 minutes from injection, the contrast agents have reached its maximum in
the cartilage and owing to this, the interface between the synovial fluid and cartilage
is harder to distinguish from the CECT images.
The diffusion of the contrast agent and the equilibrium time, the time required
to reach the diffusion equilibrium, depend mainly on the cartilage thickness. The
equilibrium time is longer the thicker the cartilage is. In addition to thickness of the
cartilage, also the size of the contrast agent affects to the equilibrium time. In the
study using the most commonly used contrast agent ioxaglate (Hexabrix, M = 1269
g/mol, q = 1) the diffusion equilibrium was reached after eight hours [41, 42, 96].
However, when the contrast agent with smaller atomic size (iodine) was used, the
equilibrium was observed already after 5 hours [96]. Because the equilibrium takes
place after several hours from administration, the equilibrium is unreachable in
clinical settings [41,42,93].
Despite the long contrast agent equilibrium times, the state of the cartilage can
be detected most sensitively before the equilibrium is reached. GAG and contrast
agent concentrations correlate already before the equilibrium has been reached [42]
allowing the detection of cartilage degeneration and injuries already after 30–60
minutes of diffusion [11]. Thus, so called delayed imaging usually at 45 minutes
after administration is required for the detection of OA since the contrast agent
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concentration is higher in the degenerated and injured cartilage than in the more
intact cartilage [10].
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4. MATERIALS AND METHODS
This research project focuses on the development of a novel dual contrast method for
delayed CT arthrography of the knee joint. The dual contrast method provides an
effective tool for the detection of articular cartilage injuries as well as the detection of
the changes in surrounding tissue in clinical practice. Moreover, the method would
also reduce the radiation dose significantly as compared to current method used in
CECT of the knee joint.
In this chapter, the preparations of the three contrast agents (Hexabrix 15%
solution, BiNP suspension, and dual contrast agents) used in this study are described
in detail. Furthermore, the protocol for the Z-Average size distribution and the zeta
potential measurements of the BiNP suspensions are introduced. The latter part
of this section describes the sample preparation along with the sample injuring.
Finally, the protocol and analysis of the CECT imaging are explained.
4.1 Contrast Agent Preparations
The planetary milling system (Fig. 4.1) consists of at least one milling jar and a
planetary milling device. In contrast agent preparetion, the materials and milling
balls are loaded into the jars and placed into the milling device. During the milling
process, the jars are rotating around the central axis and simultaneously around
their own axes in the opposite direction mimicking the movements of planets around
the Sun. The milling balls are subjected to superimposed rotational movements,
Coriolis forces. The efficiency of the grinding is the result of the high dynamic
energies caused by the difference in speeds between the milling balls as the material
particles undergo multiple collisions with the milling balls and the jar walls. Thus,
high velocity of moving milling balls create a high stress in the activated material
reducing the particle size of the material.
In our study, we measured 170 g of milling balls, 10 g of Bi2O3 (202827, nanopow-
der, 90-210 nm particle size, 99.8% trace metals basis, Sigma-Aldrich), and 30 ml of
distilled water for the both milling bowls. Then, the solution was milled for 4 hours
using a Planetary Micro Mill Pulverisette 7 (Fritsch GmbH, Rudolstadt, Germany)
milling device at a rotation speed of 500 rpm to reach the target particle size. Milling
bowls were cooled down after every 15 minutes to ensure that the temperature does
not increase excessively. After the milling, BiNP suspension was separated from
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(a) The milling jars (b) The milling device
Figure 4.1: The milling system comprises (a) the milling jars and (b) the milling device
(Planetary Micro Mill Pulverisette 7, Fritsch GmbH). The yellow powder in the jar on the
left side is bismuth oxide and the milling balls are in the jar on the right side.
milling balls using a syringe. Then, 20% of the final volume of TWEEN 80 coating
polymer (P1754, viscous liquid, Sigma-Aldrich) was added to produce more stable
solution. TWEEN 80 was chosen foe this study since it is safe and well tolerated.
Distilled water was added to the suspension to reach the final concentration of 200
mg/ml. Finally, in the preparation of the BiNP suspension, the osmolality was ad-
justed to the physiological osmolality of 308 mOsm/l [96] using NaCl (7647-14-5,
Fisher Chemicals) and the pH of the solutions was adjusted to 7.4 using acetic acid
(320099, Sigma-Aldrich).
The dual contrast agent consists of a mixture of two compounds: an iodine-
based contrast agent Hexabrix (q= -1, Mallinckrodt Inc., St.Louis, MO, USA) and
a suspension of nano-sized bismuth oxide particles coated with positively charged
TWEEN 80 surfactant developed by us. The BiNP suspension was prepared simi-
larly as described above. Hexabrix and nanoparticle suspension were transposed so
that the mixing ratio was 15% of Hexarix and 85% of BiNP suspension of the final
volume. The final concentration of bismuth oxide in the dual contrast agent was
200 mg/ml. Again the suspension was adjusted to the physiological osmolality of
308 mOsm/l and pH was adjusted to 7.4 similarly as mentioned above.
The Hexabrix 15% solution was prepared by mixing Hexabrix with phosphate-
buffered saline (PBS, for more details about PBS, see section 4.3.3). In this case,
PBS contained only 86.6 mM of NaCl to ensure that the final osmolarity of the
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Hexabrix 15% solution remains at the physiological osmolarity of 308 mOsm/l. pH of
the PBS solution was adjusted to 7.4 using NaOH. Since Hexabrix is at physiological
pH, also the final solution is at physiological pH after the mixing.
Lastly, we prepared an improved BiNP suspension to eliminate the problems
detected with the first dual contrast agent. With the improved dual contrast agent
(for more detail, see section 5) instead of using TWEEN 80 as a coating polymer, we
decided to use polyethylene glycol (PEG). Furthermore, the nanoparticle surfaces
were modified. For the improved dual contrast agent, we also decided to reduce the
bismuth oxide concentration in the final solution by half because the attenuation
of the BiNP suspension was observed to be higher than desired. Thus, the final
concentration of bismuth oxide in both the BiNP suspension and the improved dual
contrast agent was 100 mg/ml. The BiNP suspension was prepared similarly as
described previously. PEG was mixed into the BiNP suspension and stirred until
the PEG was completely dissolved. The concentration of the PEG in the BiNP
suspension and in the improved dual contrast agent was 25 mg/ml. As the PEG
requires heat energy to be able to attach covalently to the hydroxyl groups of the
BiNPs, the suspension was heated to 100 ◦C for 4 hours.
The surfaces of the nanoparticles in the improved dual contrast agent were also
modified using citric acid so that the surface charge density was modified from
positive to negative. Negative surface charge density keeps the ioxaglate and the
nanoparticles from agglomerating due to electrostatic interactions as observed with
the first dual contrast agent. The surface modification was achieved by adding 0.06
mg/ml of citric acid (251275, Sigma-Aldrich) to the BiNP suspension prior to PEG
insertion into the suspension. The pH of the improved dual contrast agent was
adjusted using sodium carbonate (451614, Sigma-Aldrich).
4.2 Analysis of the Bismuth Oxide Nanoparticle Suspension
After the preparation of the BiNP suspension, the size distribution of the nanopar-
ticles and their zeta potential were analysed. Both the size distribution and the
zeta potential was measured using a Zetasizer Nano ZS device(Malvern Instruments
Ltd, England). This device is using dynamic light scattering for the measurement
of particle size and electrophoretic light scattering to measure zeta potential of the
particles.
4.2.1 Z-Average size distribution
Z-Average size is a hydrodynamic parameter implying that it is suitable only for
particles in a dispersion or molecules in solution. Prior to the size distribution
measurement, the concentration was reduced by adding distilled water since high
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concentrations are not suitable for the size distribution measurement with Zetasizer
Nano ZS device. Then, 3 ml of the sample suspension was measured into a plastic
cuvette (FB55143, Fisherbrand) along with 0.15 ml of 5 mM citric acid solution to
stabilize the suspension. Ultrasound bath was used to remove any air bubbles in
the suspension and to break particle agglomerates because Z-Average size is very
sensitive to any changes in the sample, such as a small proportion of aggregates.
The size distribution measurement was performed in 25 ◦C. The count rate was set
to be 144.4 kcps and the duration of the measurement to 80 s. The resulting target
Z-Average size for BiNPs was set between 100 – 500 nm.
4.2.2 Zeta potential
Zeta potential is the potential difference between the dispersion medium and the
stationary fluid layer attached to the dispersed particle. The zeta potential value
gives an indication of the suspension stability. A large positive or negative zeta
potential signifies that the particles in a suspension repel each other preventing
particles from aggregating. Thus in a suspension with a low zeta potential, there are
no forces that would prevent the particles from aggregating. Generally, suspensions
with a zeta potential below -30 mV or above +30 mV are considered stable, and
suspensions with a zeta potential between -30 – +30 unstable. Nevertheless, a
suspension that has a particle density different from the dispertant density will
eventually sediment. Now, it is also good to note that the zeta potential and surface
charge density are not the same but they are related; the zeta potential and the
surface charge density are the same when the sample is dispersed into distilled water
and is thus at neutral pH.
Also in zeta potential measurement, the samples were dispersed into distilled
water to decrease the concentration to more suitable for the measurement. Prior
the use, a special zeta potential cuvette (DTS 1070, Malvern) was carefully cleaned
in a ultrasound bath with ethanol (99.5%, Altia Oy) and distilled water. Then,
the samples were pipetted into a cuvette and air bubbles and particle agglomerates
were removed by treating the cuvette and sample in the ultrasound bath. The zeta
potential measurements were conducted at room temperature.
4.3 Sample Preparation
Intact bovine knee joints were obtained within 24 hours after slaughtering at a local
abattoir (Savo-Karjalan liha Oy, Kuopio, Finland). Then, patellae were carefully
dissected from the surrounding tissues. Next, the patellae were wrapped in PBS-
soaked gauze and stored in -20 ◦C. Prior the measurement, patellae were thawed at
room temperature.
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(a) Sample preparation (b) The impact tower
height: 20 cm
The sample plug
The impactor (500g)
The sample plug
(d = 7 mm)
A patella
A osteochondral disc
Figure 4.2: (a) The osteochondral disc (d = 2.65 cm) was drilled from the upper lateral part
of the patella and the disc was divided into four equal pieces. Then, four osteochondral
plugs (d = 7 mm) were punched from each piece and the plugs were trimmed to leave
approximately 1 mm of subchondral bone under the cartilage. (b) The custom-made
impact tower was used to injure cartilage mechanically. The sample plug was placed in a
slot, and the impactor (m = 500 g) was dropped from the height of 20 cm on the sample
plug.
After thawing, osteochondral discs (diam. = 2.65 cm) were extracted from the
upper lateral part of the patella. Next, four osteochondral plugs were prepared
(diam. = 7 mm) by first dividing the disc into four pieces and then, punching
smaller osteochondral plugs from each piece (Fig.4.2(a)). Then, osteochondral plugs
were trimmed to leave approximately 1 mm of bone underneath the cartilage. After
the osteochondral plugs were prepared, two of them were injured. In this study, we
created a mechanically induced impact on one osteochondral plug (impact plug B)
and trypsin degradation for the other osteochondral plug (degraded plug C). One
of the osteochondral plugs served as a backup sample as the remaining osteochon-
dral plug served as a reference sample (reference plug A). These plugs were used in
the measurements were nanoparticles were coated with TWEEN 80. An additional
degraded plug was prepared similarly as described above for the measurement con-
ducted with PEG. All samples were initially healthy implying that there were no
visible surface fibrillation or other early degenerative changes.
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4.3.1 Mechanical impact
The samples were injured mechanically using a custom-made drop tower (Fig. 4.2(b))
by dropping a weight of 500 g on the sample from the height of 20 cm, thus the
momentum of the weight was 0.387 kgm/s at the moment of impact. The magnitude
of the impact was chosen to create minor cracks on the articular surface. This
mechanically induced defect corresponds in OA development the characteristic of
progressive fibrillation of the cartilage surface [105]. Subsequently, the mechanical
injury the sample was immersed in PBS for 2 h at room temperature to prevent any
creep deformation.
4.3.2 Enzymatic degradation
Enzymatic degradation treatment can be used to mimic the cartilage condition in
early-state OA, including disruption of superficial collagen and PG loss. However,
artificial degradation fails to demonstrate all of the complex symptoms of OA, it can
only provide some insight into PG loss and collagen disruption [106,107]. Trypsin is
one of the most commonly used enzymes to produce PG depletion [108]. Treating
the samples with trypsin, we were able to recreate the characterised signs of early-
state OA by degeneration of PGs [109]. Furthermore, trypsin has been shown to also
cleave minor amounts of collagen [110]. The degree of degradation can be managed
through the concentration of the enzyme solution and the duration of the treatment.
In enzymatic degradation, the samples were digested with trypsin solution (0.5
mg/ml) for 15 hours at 37.5 ◦C to achieve the specific level of PG depletion. Before
digestion, the sample and the trypsin solution were warmed in incubator separately
up to 37.5 ◦C. After the treatment, the samples were immersed in PBS for 2 hours.
4.3.3 Phosphate buffered saline
PBS is a balanced salt solution commonly used in biological laboratories. PBS is
isotonic meaning that the osmolarity and ion concentrations of the solutions cor-
respond to that in a human body. Thus, PBS maintains the physiological pH and
osmotic balance of the cell along with providing cells with water and essential in-
organic ions. PBS can maintain cells suitable environment for the short term while
the cells are examined outside of their regular environment.
During preparation, the samples were kept moist with PBS, including 6.4 mM
ethylenediaminetetraacetic acid (EDTA) and 6.4 mM benzamide as inhibitors of
proteolytic enzymes. PBS is made by dissolving the reagents into the distilled water
so that the final concentration of the reagents are as follows: NaCl 137 mM, KCl 2.7
mM, Na2HPO4 10 mM, and KH2PO4 1.8 mM. The pH of the solution was adjusted
to the physiological pH of 7.4 with NaOH.
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Figure 4.3: (a) A magnified microCT image of a representative sample plug (averaged
over 201 consecutive image slices) obtained in this study. The cartilage can be seen in
the image as the region which is the darkest. The analysed area is outlined in the picture
as red. The width of the analysis area was 2790 µm (201 pixels), and the height was
chosen for every sample to leave enough subchondral bone and contrast agent around the
cartilage. (b) The magnified image of the analysed area. (c) The X-ray attenuation profile
along the vertical direction. The pixel rows are horizontally averaged from the subfigure
(b) to obtain the X-ray attenuation profile.
4.4 Contrast Enhanced Computed Tomography Imaging
The imaging was performed for each sample (reference plug A, impact plug B, and
degraded plug C) with three different contrast agents (Hexabrix 15% solution, BiNP
suspension, and dual contrast agent) using a microCT-instrument (Skyscan 1172,
SkyScan, Kontich, Belgium). The imaging order of the contrast agents was selected
randomly for every osteochondral plug. The imaging was conducted immediately
after the sample plug immersion into the contrast agent and after 45 minutes from
the immersion. The tube voltage was 100 kV, the tube current 100 mA, and the
isotropic voxel size 13.88 × 13.88 × 13.88 µm3. The acquisition time for one imaging
was approximately 12 minutes. To ensure that the diffusion of the contrast agent
occurs only trough the articulating surface, the sides of the osteochondral plugs were
sealed with cyanoacrylate. Furthermore, the sample plugs were imaged upside down
(i.e. articulating surface towards bottom of the sample tube, as shown in Fig. 4.3
(a)) to the prevent any accrual of the nanoparticles on the surface of the cartilage
due to gravitation. After each imaging with different contrast agent, the samples
were immersed in an isotonic bath of PBS (60 ml) for two hours at 9 ◦C to wash out
the contrast agent. The time was found to be enough for washing the contrast agent
out from the cartilage entirely by imaging the sample plug in PBS with microCT
by comparing the baseline image od the cartilage with preliminary tests.
Imaging data was analysed using MATLAB (R2014a, MathWorks, Inc., Natick,
MA, USA). At first, microCT image stacks were co-registered for 0-minute and 45-
minute time points. Signal-to-noise-ratio was improved by averaging 201 spatially
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consecutive coronal slices for both time points. The width of the region of interest
(ROI) was selected to be 2790 µm (201 pixels) at the center of the each osteochondral
plug (Fig. 4.3(a)). The pixel rows in the ROI were also averaged in the horizontal
direction to obtain the depth-wise attenuation profile (Fig. 4.3(c)). The contrast
agent diffusion into cartilage was examined by comparing the 0-minute and 45-
minute attenuation profiles.
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5. RESULTS AND DISCUSSION
The aim of this thesis is to evaluate the feasibility of usage of the dual contrast agents
in the detection of the fresh cartilage injuries. To this end, new dual contrasts agent
is prepared (see Section 4). In this chapter the properties of the developed dual
contrast agent is shown. Also, the initial imaging result using three contrast agents
(Hexabrix 15% solution, BiNP suspension, and dual contrast agent (with TWEEN
80 coating polymer)) along with the preliminary microCT imaging results of the
improved contrast agent (with PEG coating polymer) are presented. Furthermore,
the feasibility of the suggested dual contrast method will be evaluated in the light
of current results at the end of this chapter.
5.1 The First Bismuth Oxide Nanoparticle Suspension
Before using new contrast agents in imaging, the properties, such as nanoparticle
size and stability, of the prepared solution need to be resolved to evaluate whether
the solution is suitable for practical use. For example, if the nanoparticle size is
too small, the particles are free to diffuse into cartilage. On the other hand, if the
particle size is too large, a nanoparticle size close to 1 µm would cause damage to
cartilage in vivo as micrometer-sized particles can grind the surface of the cartilage,
thus inducing incipient degeneration to the cartilage.
To obtain the size range of the particles in the BiNP suspension, the Z-Average
size distribution was measured (see Fig. 5.1 (a)). The mean size of the nano-particles
were obtained to be 261.2 nm with the standard deviation of 82.33 nm. Thus, the
nanoparticles were large enough to be unable to diffuse into cartilage because the
estimated average pore size of cartilage is approximately 6.0 nm [111].
Polydispersity Index (PdI) describes the uniformity of the particles in a suspen-
sion in terms of theirs size. PdI is a dimensionless variable calculated from a simple
two parameter fit to the correlation data. PdI values smaller than 0.05 are rare
and represents highly monodisperse dispersion. Values greater than 0.7, conversely,
represents a sample that has a very broad size distribution and is hence unsuitable
for the Z-Average size measurement utilising dynamic light scattering technique. In
this light, the measured PdI value of 0.171 indicated that the BiNP suspension is
relatively monodispersed.
The zeta potential is used to describe the properties of the particles, such as
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Figure 5.1: (a) Z-Average size distribution of Bi203 nanoparticle suspension by intensity.
Average size was measured to be 261.2 ± 82.4 nm and PdI to be 0.171. (b) Zeta potential
distribution of Bi203 nanoparticle suspension. Zeta potential was measured to be 58.3 ±
9.3 mV. (c) Zeta potential distribution of Bi203 nanoparticle suspension with TWEEN 80
coating polymer. Zeta potential was measured to be 60.5 ± 10.2 mV.
stability, in a suspension. The obtained zeta potential distributions (see Fig 5.1
(b,c)) of BiNP suspension were obtained to be 58.3 mV and 60.5 mV for suspension
without coating polymer and with TWEEN 80, respectively. Thus, both of these
suspensions can be considered stable since in general the zeta potential values below
-30 mV or above +30 mV are consider to show the stability of the suspension.
However, with the particles of this magnitude, the suspensions are settling under
gravity with time. TWEEN 80 coating polymer was noticed to slow down the settling
of the nanoparticles (data not shown).
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5.2 Contrast Enhanced Computed Tomography
The results of this section are divided based on the used dual contrast agent. In
the first dual contrast agent, TWEEN 80 was used as a coating polymer while in
the improved dual contrast agent the TWEEN 80 was replaced by PEG. Also, the
surfaces of the nanoparticles were modified for the improved dual contrast agent.
5.2.1 The First Dual Contrast Agent - MicroCT Images
MicroCT images are a useful and fast way to visually evaluate the condition of
the articular cartilage but for more detail X-ray attenuation profiles can be used
to provide more detailed information about the condition of the cartilage. The
visual evaluation of the microCT images can be done by comparing the images
conducted immediately after the contrast agent immersion and 45 minutes after the
immersion. Cartilage injuries can be detected by observing the changes in contrast
agent diffusion into cartilage as a higher X-ray attenuation.
Hexabrix is one of the most commonly used contrast agent in the CECT, and
in this study it will serve as a reference for the dual contrast agent as we compare
the ioxaglate diffusion into cartilage. The microCT images of the three samples (the
reference plug, the impact plug, and the degraded plug) at 0 minutes and 45 minutes
after Hexabrix 15% solution immersion are shown in Fig. 5.2. As can be seen, the
contrast agent diffusion into the mechanically injured and enzymatically degraded
cartilage is greater than into reference cartilage. Furthermore, the visual detection
of cartilage surface changes (such as cracks in the cartilage-contrast agent interface)
is challenging or even impossible with Hexabrix 15% solution. However, this might
be due to fact that for these images we averaged 201 spatially consecutive coronal
slices and thus, the information of the surface changes might have been lost if the
changes in the surface were much smaller than the selected ROI.
The contrast at the interface between the contrast agent and cartilage could
be retained at high level by implementing nano-sized bismuth nanoparticles. The
improved contrast at the cartilage-contrast agent interface would also enable the
detection of cartilage surface changes. Thus, to study the potential of nanoparticles,
the samples were imaged using BiNPs suspension. The microCT images of all three
sample plug at both time points using BiNP suspension are presented in the Fig. 5.3.
Based on our hypothesis, using nano-sized particles, such as bismuth oxide nanopar-
ticles, the contrast of the interface between the cartilage and contrasta agent can
be retained at high level, and the changes in cartilage surface could be obtained
more clearly. To this end, similar images as shown above were taken by using the
BiNP suspension (see Fig. 5.3). It can be seen that the interface between cartilage
and surrounding contrast agent remains distinct. This implies that the selected size
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Figure 5.2: MicroCT images of the sample plugs using Hexabrix 15% solution. Images are
averaged over 201 consecutive image slices. Hexabrix 15% solution allows the detection
of cartilage injuries as elevated contrast agent concentration in the injured site. However,
the evaluation of surface changes, such as crack, is challenging.
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Figure 5.3: MicroCT images of the sample plugs using bismuth oxide nanoparticle sus-
pension. Images are averaged over 201 consecutive image slices. BiNPs maintain the high
contrast at the cartilage-contrast agent interface and allow the detection of cracks and
other surface lesions. Nevertheless, diagnostics of subsurface injuries is infeasible.
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of nanoparticles is large enough for keeping nanoparticles from diffusing into the
cartilage despite the cartilage condition. Furthermore, the cracks and other surface
unevenness can be detected easily from the microCT images of the impact plug with
both 0-minute and 45-minute images (Fig. 5.3(c)-(d)). However, it is impossible
to say anything about the condition of the cartilage under the surface i.e. inter-
nal lesions and loss of PGs. For example, there is no visible difference in reference
plug and degraded plug even though it is known that the degraded plug suffers from
severe loss of PGs and thus, the PG related changes in cartilage would get unnoticed.
Another interesting feature is that the bismuth oxide is agglomerating on the
surface of the cartilage and especially to the cracks of the mechanically injured
cartilage. This is most probably due to opposite charges of the cartilage and the
nanoparticles. As previously mentioned, GAG molecules are negatively charged
inducing an overall negative charge to the cartilage surface. On the contrary, the
BiNPs have a high positive zeta potential implying high positive surface charge
density. Thus, nanoparticles are drawn near the surface of the cartilage due to
electric attraction. Since the sample plugs were imaged upside down, the gravity is
irresponsible for the accumulation of the BiNP on the surface of the cartilage. This
accumulation of the BiNPs on the surface of the cartilage would make the detection
of superficial cartilage lesions, as well as the segmentation of the cartilage-contrast
agent interface significantly easier as the contrast in articulating surface improves.
Since there is no knowledge about the secession of the positively charged nanopar-
ticles attached to the cartilage surface in vivo, we decined the develop a improved
dual contrast agent. For this reason, the BiNP surfaces were modified to change the
surface charge density from postive to negative to prevent the nanoparticles from
aggregating on the cartilage surface.
Since our dual contrast agent is a mixture of the Hexabrix 15% solution and
the BiNP suspension, it should reflect all the good qualities observed with these
two contrast agents. The dual contrast agent should allow the diagnostics of fresh
cartilage injuries and degenerations conducting only one image 45 minutes after dual
contrast agent administration. Thus, ioxaglate molecules should be able to diffuse
into catilage freely, and nanoparticles should be able to maintain the high contrast
at the cartilage-contrast agent interface. The microCT images at both time points
using dual contrast agent for all three sample plugs are presented in the Fig. 5.4.
The lesions of the surface induced by the mechanical impact can be detected easily
as the contrast at the cartilage-contrast agent interface remain remarkably distinct
even 45 minutes after the immersion into dual contrast agent. However, as the
contrast between the cartilage and surrounding contrast agent increases considerably,
the visual evaluation of the contrast agent diffusion into the cartilage becomes more
challenging. Thus, the more detailed evaluation of the contrast agent diffusion into
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Figure 5.4: MicroCT images of the sample plugs using dual contrast agent. Images are
averaged over 201 consecutive image slices. With the dual contrast agent the detection
of superficial injuries is possible from the microCT images conducted 45 minutes after
dual contrast agent immersion as we hyphotesized. However, based on these images, the
evaluation of subsurface injuries is challenging.
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cartilage have to be done by comparing the attenuation profiles.
5.2.2 The First Dual Contrast Agent - X-ray Attenuation Pro-
files
X-ray attenuation profiles are providing more detailed information about the con-
dition of the cartilage. The attenuation profiles along the vertical direction of both
damaged sample plugs in comparison with the reference plug immediately and 45
minutes after the immersion into the Hexabrix 15% solution are presented in Fig. 5.5.
As can be seen, the X-ray attenuation profiles as the cartilage part are similar for
every cartilage plug immediately after the sample plugs are immersed into Hexabrix
15% solution.
At 45 minutes after the immersion, the X-ray attenuation is higher in mechanically
injured and enzymatically degraded cartilage. In both 45-minute images, the X-ray
attenuation has increased more as compared to the reference plug. This implies that
the diffusion of the contrast agent into cartilage is greater in both impact plug and
degraded plug as compared to the reference plug. In a recent study by Kokkonen et
al., histological analyses showed that mechanically injured tissue undergoes a minor
PG loss [11]. Thus, the PG loss is at least partly responsible for the increased
diffusion of the contrast agent into injured cartilage. Other reasons for greater
contrast agent diffusion into mechanically injured cartilage may include additional
structural and compositional changes e.g. in collagen and water content. These
changes can increase the permeability of the cartilage and reduce the steric hindrance
of collagen. The increased X-ray attenuation in damaged cartilage can be also
visually observed from microCT images (Fig. 5.2). This perception has already
been shown in previous studies [10] and [11]. Also for enzymatically degraded
cartilage, the main reason for higher X-ray attenuation is the PG loss but also other
structural and compositional changes that increase the contrast agent diffusion into
degraded cartilage.
In Fig. 5.6 the attenuation profiles of the injured sample plugs are presented
along the vertical direction in comparison with the reference plug immediately and 45
minutes after the immersion into the BiNP suspension where BiNPs were coated with
TWEEN 80. Firstly, since the attenuation profile of the cartilage remains unchanged
from the 0-minute to 45-minute attenuation profile we can state that the BiNPs are
not diffusing into cartilage as hyphotesized. Thus, the nanoparticles maintain the
distinctiveness of the interface between cartilage and surrounding contrast agent
as hypothesized. These results were already observed from the microCT images
(Fig. 5.3).
In addition, the gathering of the bismuth oxide on the surface of the cartilage and
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(b) reference plug versus impact plug (45 min)
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(c) reference plug versus degraded plug (0 min)
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(d) reference plug versus degraded plug (45 min)
Figure 5.5: The attenuation profiles along the vertical direction using the Hexabrix 15%
solution. The mechanically injured sample plug is compared with the reference plug (a)
immediatelly after the contrast agent immersion and (b) 45 minutes after the immersion.
The enzymatically degraded sample plug is compared with the reference plug (c) imme-
diatelly after the contrast agent immersion and (d) 45 minutes after the immersion. The
X-ray attenuation profiles of the reference plug are represented as blue and the X-ray
attenuation profiles of the injured plugs are represented as red.
especially to the cracks of the mechanically injured cartilage can be seen also from
the attenuation profiles as high peaks in Fig. 5.6. Owing to bismuth oxide gathering
to the cracks of the mechanically injured sample plug, it is also easy to estimate the
depth of the cracks caused by the impact with the BiNP suspension.
The X-ray attenuation profiles along the vertical direction of both injured sample
plugs in comparison with the reference plug immediately and 45 minutes after the
immersion into the dual contrast agent are presented in Fig. 5.7. In cartilage the
attenuation profile should be similar to that imaged with Hexabrix 15% solution
since the ioxagalte molecules should be able to move freely in the dual contrasta
5. Results and Discussion 47
0 50 100 150 200 250 300 350
0.5
1
1.5
2
2.5
3
3.5
x 10
4
Distance (pixels)
X
−
ra
y
 a
tt
en
u
at
io
n
 (
A
.U
.)
Contrast 
agent
CartilageBone
(a) reference plug as blue versus impact plug as
red (0 min)
0 50 100 150 200 250 300 350
0.5
1
1.5
2
2.5
3
3.5
x 10
4
Distance (pixels)
X
−
ra
y
 a
tt
en
u
at
io
n
 (
A
.U
.)
(b) reference plug versus impact plug (45 min)
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(c) reference plug versus degraded plug (0 min)
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(d) reference plug versus degraded plug (45 min)
Figure 5.6: The attenuation profiles along the vertical direction using BiNP suspension.
The mechanically injured sample plug is compared with the reference plug (a) immedi-
atelly after the contrast agent immersion and (b) 45 minutes after the immersion. The
enzymatically degraded sample plug is compared with the reference plug (c) immediatelly
after the contrast agent immersion and (d) 45 minutes after the immersion. The X-ray
attenuation profiles of the reference plug are represented as blue and the X-ray attenuation
profiles of the injured plugs are represented as red.
agent similarly as in Hexabrix 15% solution. The X-ray attenuation profiles of the
injured sample plug should be above the reference X-ray attenuation profile. Now,
however, the ioxaglate in the dual contrast agent is unable to reach the same level
of diffusion as in the Hexabrix 15% solution (Fig. 5.5 (d) vs. Fig. 5.7 (d)). Thus, we
think that ioxaglate is not as free to diffuse into cartilage in dual contrast agent as in
the Hexabrix 15% solution. This might be due to opposite charges of the ioxaglate
molecules and BiNPs in the dual contrast agent causing the ioxaglate molecules and
nanoparticles to agglomerate.
Another problem with this dual contrast agent is the especially high contrast
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(b) reference plug versus impact plug (45 min)
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(c) reference plug versus degraded plug (0 min)
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(d) reference plug versus degraded plug (45 min)
Figure 5.7: The attenuation profiles along the vertical direction using the dual contrast
agent. The mechanically injured sample plug is compared with the reference plug (a)
immediatelly after the contrast agent immersion and (b) 45 minutes after the immersion.
The enzymatically degraded sample plug is compared with the reference plug (c) imme-
diatelly after the contrast agent immersion and (d) 45 minutes after the immersion. The
X-ray attenuation profiles of the reference plug are represented as blue and the X-ray
attenuation profiles of the injured plugs are represented as red.
at the cartilage-contrast agent interface. This high contrast is unavailing for our
purpose and thus signifying that the contrast could be decreased. This means that
the concentration of the bismuth oxide could be decreased in the dual contrast agent
decreasing also the concentration-dependent cytotoxicity of the dual contrast agent.
5.3 Improved Dual Contrast Agent
There are also a few factors that need to be solved before the dual contrast method
can be implemented to more extensive studies. A major challenge in using nanopar-
ticles in clinical use is their exposure for high salinity. High inorganic ion concen-
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tration can affect the stability of the suspension. Inorganic ions can interact with
charged surfaces of the nanoparticles, thus changing the zeta potential of the parti-
cle suspension. In the worst case, inorganic ion adsorption can even lead to charge
reversal of the surface decreasing the repulsive forces of the nanoparticles. Thus, ad-
justing the osmolarity of the suspension to the physiological osmolarity with NaCl is
probably disturbing the stability of the suspension as well as causing aggregation of
the nanoparticles at some level. Aggregation occurs whenever the Brownian motion
and the attractive forces of the particles are greater than the repulsive forces [112].
Secondly, the stability of the suspension could be improved further. First, the
stability improves as the concentration of the nanoparticle suspension decreases.
Thus, another reason behind the decision to decrease the concentration of bismuth
oxide for the improved dual contrast agent was to achieve more stable nanoparticle
suspension. Second, the stability of the suspension can be improved by choosing a
different coating polymer. According to our preliminary tests with different coating
polymer, PEG turned out to produce the most stable suspension and thus for the
improved dual contrast agent TWEEN 80 was replaced by PEG. The nanoparticles in
TWEEN 80 suspension were observed to settle down in a shorter time as the sample
tubes containing both suspensions were kept on the table stationary during the
monitoring. The consistency of the resulting suspension was also another advantage
of PEG over TWEEN 80. Usage of TWEEN 80 changed the consistency of the BiNP
suspension more into foam-like which made the suspension containing TWEEN 80
challenging to apply for CECT imaging.
Thirdly, the charge of the nanoparticles could be changed to keep nanoparticles
and ioxaglate molecules from adhering together due to electrostatic forces by the
surface modification. In the first batch of BiNP solution, the nanoparticles were
charged positively as the ioxaglate molecules had negative charge. By changing the
charge of the nanoparticles to negative, a strong repulsion between nanoparticles
and ioxaglate molecules can be generated in the dual contrast agents. To prevent
aggregation, the surface of the nanoparticles was modified to have negative charge
density using citric acid. The zeta potential distribution of the PEG-coated BiNP
suspension and the surface modified BiNP suspension is shown in Fig. 5.8. Zeta
potential was measured to be 59.1 for PEG-coated and -38.3 mV surface modified
BiNP suspension which implied that the stability of both suspensions is good. Zeta
potential of the surface modified BiNP suspension also implies that the nanoparticles
have negative surface charge density close to measured zeta potential since the zeta
potential measurement was conducted in distilled water at neutral pH.
With the first dual contrast agent, in which the BiNPs were coated with TWEEN
80, we observed that the ioxaglate penetration into cartilage in dual contrast agent
was not corresponding the ioxaglate penetration in Hexabrix 15% solution. Thus
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Figure 5.8: (a) Zeta potential distribution of BiNP suspension with PEG coating polymer.
Zeta potential was measured to be 59.1± 9.1 mV. (b) Zeta potential of the surface modified
BiNP suspension. Zeta potential was measured to be -38.3 ± 6.28 mV.
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Figure 5.9: The X-ray Attenuation profiles of cartilage at both time points with the
improved dual contrast agent and Hexabrix 15% solution. The average X-ray attenuation
value of cartilage before the contrast agent immersion (i.e. baseline) was subtracted from
that after the immersion. In this way, only the attenuation profile of the ioxaglate in
the cartilage is achieved. The surface of the articulatingcartilage is on the left and the
cartilage-bone intreface on the right.
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as a first test with the improved dual contrast agent, we compared the ioxaglate
penetrations with Hexabrix 15% solution using a degraded osteochondral plug. The
results of this preliminary test are presented in Fig. 5.9. Now, the attenuation
profiles show that the penetration of ioxaglate in improved dual contrast agent cor-
responds the ioxaglate penetration observed with the Hexabrix 15% solution. Thus,
the dual contrast agent seems to have over come the challenges observed during the
preparation of the first dual contrasts agent and is hence ready for more extensive
studies.
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6. CONCLUSIONS
In this thesis, the potential and feasibility of the dual contrast method for CECT
diagnostics of cartilage injuries in vitro was developed and introduced for the first
time. Using the current methods, articular cartilage lesions are diagnosed conducting
CECT images immediately after and at 45 minutes after contrast agent injection
into the synovial fluid. The first image is required for accurate segmentation of
the cartilage surface since the contrast between the cartilage and synovial fluid
deteriorates due to contrast agent diffusion into cartilage. Delayed imaging, at 45
minutes after the administration, allows the detection of cartilage injuries as elevated
contrast agent concentration at injured or degenerated tissue. However, according
to our hypothesis, the dual contrast method would enable simultaneous imaging
of cartilage lesions and segmentation of the cartilage-contrast agent interface from
image conducted 45 minutes after the contrast agent administration into the synovial
fluid. Thus as an outcome, the dual contrast method would enhance the diagnostics
of fresh cartilage injuries and enable better planning of repair operations.
The feasibility of the dual contrast method was evaluated by imaging osteochon-
dral plugs in three different contrast agents (Hexabrix 15% solution, BiNP suspen-
sion, and dual contrast agent) using a microCT device. Two of the plugs were
injured; one mechanically and other enzymatically. The remaining osteochondral
plug served as a reference. The dual contrast agent, developed in this study, is a
mixture of an iodine-based contrast agent ioxaglate (Hexabrix) and a suspension
of nano-sized bismuth oxide particles. The large size of the nanoparticles prevents
them from diffusing into cartilage; hence, the contrast at the synovial fluid-cartilage
interface can be retained at a high level due to the nanoparticles, even at the 45
minutes after the contrast agent administration. Conversely, the diffusion of the
ioxaglate into cartilage allows the quantitative evaluation of the cartilage composi-
tion. As a result, the condition of the cartilage can be evaluated conducting only
one image after 45 minutes from the contrast agent administration.
At the beginning, the first version of the dual contrast agent was tested. This
dual contrast agent, however, was unable to meet the requirements that we had for
the nanoparticle suspension. First of all, the stability of the contrast agent was poor.
Secondly, the positive surface charge caused the nanoparticles to agglomerate with
the ioxaglate molecules in the dual contrast agent. For these reasons, we prepared
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another improved dual contrast agent containing PEG as a coating polymer and
modified the surface charge density of the nanoparticles from positive to negative
to avoid too strong interactions between the nanoparticle and cartilage tissue which
may be harmful in vivo.
The improved dual contract agent was tested with an enzymatically degraded
osteochondral plug. Obtained results were promising since this time the ioxaglate
molecules were able to diffuse into cartilage similarly as in the situation where only
Hexabrix 15% solution was used as a contrast agent. This implies that with the
improved dual contrast agent, the condition of the cartilage can be evaluated as
we hypothesised. However, further research needs to be conducted to verify the
feasibility of the dual contrast method.
As a long-term goal, we are aiming to introduce the dual contrast method for
the clinical use. However in the clinical use, two factors will slightly decrease the
sensitivity of the dual contrast method. Firstly, the contrasts agents are diluted
into synovial fluid reducing the concentration of the ioxaglate and BiNP in the final
solution. Secondly, the eﬄux of the contrast agent from the joint capsule after
the contrasts agent administration into synovial fluid will also slightly reduce the
concentration. Furthermore, the resolution of clinical CT devices is lower (usually
>200 µm) making, for example, the detection of cartilage surface changes more
challenging. The difficulty of detecting cracks and other surface changes with lower
resolution is mainly due to partial volume effect as well as decreases number of pixels
representing a crack in the cartilage surface. To examine the applicability of the dual
contrast method in clinical use more profoundly, the method will also be tested in
cadaveric human knee in situ as well as in equine joints in vivo later in the future.
To conclude, the dual contrast method seems to be a useful tool for the fresh
cartilage injury diagnostics but the method can be still improved further. The
next step in this project is to conduct more extensive microCT measurements with
ten new patellae to study the feasibility of dual contrast method for more detailed
cartilage injury diagnostics in a long way to final product to be utilized in clinical
use.
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